ch156_lecture5 autoradiography
TRANSCRIPT
-
7/22/2019 CH156_Lecture5 Autoradiography
1/12
Chemistry 156: Chemistry of Positron Emission Tomography
Lecture 4:
Autoradiography
-
7/22/2019 CH156_Lecture5 Autoradiography
2/12
Autoradiography - Background
Autoradiography is any technique used to produce an image of the
2D distribution of a radioactive substance.
-The first autoradiography was obtained
accidently around 1867 when ablackening was produced on emulsions
of silver chloride and iodide by uranium
salts.
- uc s u es an e wor o e ur es
in 1898 demonstrated autoradiography
before, and contributed directly to, the
discovery of radioactivity.
-The development of autoradiography as a
biological technique really started tohappen after World war II with the
development of photographic
emulsions and then stripping film made
of silver halide.
-
7/22/2019 CH156_Lecture5 Autoradiography
3/12
Autoradiography First use for drug binding
- Determined binding of a [3
H]-labeled opioid peptide, [3H]-
morphine, and derivatives
- Pretreated with opioid drugs todetermine specific binding
-
7/22/2019 CH156_Lecture5 Autoradiography
4/12
General Methods for Autoradiography
Two General Types of Experiments:
1) In-vivoautoradiography - receptors are labeled in intact living tissue by systemicadministration of the radioligand (like in PET). Tissue is removed, processed, and
visualized.
2) In-vitroautoradiography - slide-mounted tissue sections are incubated withradioligand so that receptors are labeled under very controlled conditions
Radionuclide Half-life Theoretical SA(Ci/mmol)
Decay mode
14C 5730 years 0.0624
3H 12.43 years 28.8*
35S 87.4 days 1494
32P 14.3 days 9131
125I 60.0 days 2176
131I 8.04 16240
-
7/22/2019 CH156_Lecture5 Autoradiography
5/12
General Technique
- Map anatomical location of radiolabelled ligands to visualize andquantify receptors in tissue
- Trace neurons by axonal transport of radioactively labeled aminoacids, certain sugars, or transmitter substances
- Measure DNA production (e.g., 3H-thymidine)
Examples uses for autoradiography:
Board 1
-
7/22/2019 CH156_Lecture5 Autoradiography
6/12
Important considerations: Validation of Protocol
- Binding must be linear with respect to receptor density over the
range in which the assay will be used.
- The stability of the ligand should be measured to make sure it stays
intact over the time-course of the experiment
- The stability at integrity of the target (receptor/enzyme/etc) should
e ver e . or examp e, oes ssue process ng mpac n ng .
Board 2
-
7/22/2019 CH156_Lecture5 Autoradiography
7/12
Kinetics of Binding
Unlike PET imaging in vivo, we have control over the
timing of the experiment and can verify that equilibrium
is reached.
Boards 3-8
-
7/22/2019 CH156_Lecture5 Autoradiography
8/12
Autoradiography Detection with Film
Grain
Autoradiographic film is typically composed of 4 layers.
1- An upper protective coat.
2- A layer of gelatin that contains silver halide (AgBr, AgCl, or AgI)
crystals. (The type and proportions of the different silver halides
determining the speed of the film.)
3- The film base, usually made from a flexible polymer.
4- An anti-halation backing to prevent light from reflecting back
onto the emulsion.
-
7/22/2019 CH156_Lecture5 Autoradiography
9/12
Autoradiography Detection with Film
-particles
Film before exposure
Exposure of film to sample
Formation of latent image
Fixing removes unreacted silver halides
from the emulsion.
Development changes silver ions to
metallic silver
-
7/22/2019 CH156_Lecture5 Autoradiography
10/12
Autoradiography Detection with Film
Boards 9-12
-
7/22/2019 CH156_Lecture5 Autoradiography
11/12
Radiotracer of the Day [18F]-FMISO
[18F]Fluoromisonidazole is a hypoxia marker.
Hypoxia (oxygen deprivation) in malignant tumors can affectthe outcome of anti-cancer treatments. Malignant tumors are
relatively resistant to chemotherapy and irradiative therapybecause of their lack of oxygen, a potent radiosensitizer.
-
7/22/2019 CH156_Lecture5 Autoradiography
12/12
Radiotracer of the Day [18F]-FMISO
Brain Tumor - Glioblastoma
FMISO FDG MRI
Nonsmall Cell Lung Carcinoma
FMISOFDG CT